Pfizer Recalls Hydromorphone Hydrochloride Injection Due to Sterility Assurance Concerns
Pfizer is recalling 115,370 vials of Hydromorphone Hydrochloride Injection because a damaged sterilizing filter may have compromised sterility assurance during manufacturing.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall involving a lack of sterility assurance in an injectable drug, which poses a risk of serious adverse health consequences such as infection, meeting the criteria for a Severe rating.
Plain-English summary
Pfizer Inc. is recalling 115,370 vials of Hydromorphone Hydrochloride Injection, USP, 2 mg/mL, 1mL Single-use vial. The product is packaged in cartons of 25 vials and is available by prescription only. The specific lot number is 760853A, and the NDC numbers are 0409-3365-11 (carton) and 0409-3365-01 (vial). The product was manufactured by Hospira, Inc., in Lake Forest, IL.
The recall was initiated due to a lack of sterility assurance. This issue resulted from the use of a damaged sterilizing filter for nitrogen during the manufacturing process. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
The affected product was distributed nationwide in the United States, including Puerto Rico, as well as in Singapore. Healthcare providers and patients should check their inventory for this specific lot number and discontinue use if found. Consumers should contact their healthcare provider or pharmacist for guidance on alternative treatments if they have been prescribed this medication.
The recalled product
- Product
- HYDROMORPHONE HYDROCHLORIDE (HYDROMORPHONE HYDROCHLORIDE)
- Brand
- HYDROMORPHONE HYDROCHLORIDE
- Manufacturer
- Pfizer Inc.
- Affected units
- 115,370
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 760853A
Distribution
Part of a larger recall action
This product is one of 2 recalled by Pfizer Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · HYDROMORPHONE HYDROCHLORIDE
- SeverePfizer Recalls Hydromorphone Hydrochloride Injection Vials Due to Non-Sterility
FDA (Drugs) · 2018-03-21
- CriticalPfizer Recalls Hydromorphone Hydrochloride Injection Due to Non-Sterility Concerns
FDA (Drugs) · 2018-03-21
- ModerateHospira Recalls Hydromorphone Hydrochloride Injection Due to Silicone Oil Particulates
FDA (Drugs) · 2017-08-16
- ModerateHospira Recalls Hydromorphone Hydrochloride Injection Due to Silicone Oil Particulates
FDA (Drugs) · 2017-08-16
- SevereHospira Recalls Hydromorphone Hydrochloride Injection Due to Silicone Oil Particulates
FDA (Drugs) · 2017-08-16
Same manufacturer · Pfizer Inc.
See all →- HighSodium bicarbonate injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighEpinephrine injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighBicillin L-A 2.4 million unit vials recalled after particulates found
FDA (Drugs) · 2025-08-06
- HighBicillin L-A penicillin vials recalled after particulates found during visual inspection
FDA (Drugs) · 2025-08-06
- ModerateDobutamine Injection Recall Due to Discoloration and Cracked Vials
FDA (Drugs) · 2025-07-02
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow access trays and PSI kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24